Kumar, R., Singh, S. K., Singh, S., & Kumar , A. (2025). Addressing cardio-metabolic risks in type 2 diabetes: evidence-based insights on efpeglenatide. International Journal of Basic & Clinical Pharmacology, 14(4), 565–582. https://doi.org/10.18203/2319-2003.ijbcp20251843